MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis

References

• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
   PubMed Web of Science ®Google Scholar
• Zeng L, Liao Q, Zeng X, et al. Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered. 2022;13(2):2623–2638.
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (Concord-2). Lancet. 2015;385(9972):977–1010.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Hou L, et al. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16(1):151.
   PubMed Web of Science ®Google Scholar
• Yuan G, Ding W, Sun B, et al. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance. Bioengineered. 2021;12(1):4936–4945.
   PubMed Web of Science ®Google Scholar
• Huang YK, Yu JC. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: an update and review. World J Gastroenterol. 2015;21(34):9863–9886.
   PubMed Web of Science ®Google Scholar
• Zhao R, Zhang Y, Zhang X, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer. Mol Cancer. 2018;17(1):68.
   PubMed Web of Science ®Google Scholar
• Shan C, Zhang Y, Hao X, et al. Biogenesis, functions and clinical significance of circRNAs in gastric cancer. Mol Cancer. 2019;18(1):136.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang X, Cai Z, et al. A novel class of microRNA-recognition elements that function only within open reading frames. Nat Struct Mol Biol. 2018;25(11):1019–1027.
   PubMed Web of Science ®Google Scholar
• Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482(7385):347–355.
   PubMed Web of Science ®Google Scholar
• Li T, Guo H, Li H, et al. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia. Gut. 2019;68(10):1751–1763.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun J, Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62.
   PubMed Web of Science ®Google Scholar
• Cojocneanu R, Braicu C, Raduly L, et al. Plasma and tissue specific miRNA expression pattern and functional analysis associated to colorectal cancer patients. Cancers (Basel). 2020;12(4):843.
   PubMed Web of Science ®Google Scholar
• Hussein NA, Kholy ZA, Anwar MM, et al. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. J Cancer Res Clin Oncol. 2017;143(1):83–93.
   PubMed Web of Science ®Google Scholar
• Jung AR, Eun YG, Lee YC, et al. Clinical significance of CUB and sushi multiple domains 1 inactivation in head and neck squamous cell carcinoma. Int J Mol Sci. 2018;19(12):3996.
   PubMed Web of Science ®Google Scholar
• Escudero-Esparza A, Bartoschek M, Gialeli C, et al. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer. Oncotarget. 2016;7(47):76920–76933.
   PubMedGoogle Scholar
• Lee JH, An CH, Kim MS, et al. Rare frameshift mutations of putative tumor suppressor genes CSMD1 and SLX4 in colorectal cancers. Pathol Res Pract. 2018;214(2):325–326.
   PubMed Web of Science ®Google Scholar
• Chen XL, Hong LL, Wang KL, et al. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-kappaB pathway. Int J Biol Sci. 2019;15(10):2075–2086.
   PubMed Web of Science ®Google Scholar
• Tang MR, Wang YX, Guo S, et al. CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the smad pathway. Apoptosis. 2012;17(9):927–937.
   PubMed Web of Science ®Google Scholar
• Jia A, Xu L, Wang Y. Venn diagrams in bioinformatics. Brief Bioinform. 2021;22(5):bbab108.
   PubMed Web of Science ®Google Scholar
• Tiruppathi C, Soni D, Wang DM, et al. The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation. Nat Immunol. 2014;15(3):239–247.
   PubMed Web of Science ®Google Scholar
• Kotlarek M, Kubiak A, Jazdzewski K, et al. MicroRNA analysis using the quantitative real-time PCR reaction. Methods Mol Biol. 2018;1823:69–85.
   PubMedGoogle Scholar
• Schmittgen TD, Livak KJ, Tiruppathi C. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.
   PubMed Web of Science ®Google Scholar
• Mruk DD, Cheng CY. Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits. Spermatogenesis. 2011;1(2):121–122.
   PubMedGoogle Scholar
• Xu YZ, Kanagaratham C, Jancik S, et al. Promoter deletion analysis using a dual-luciferase reporter system. Methods Mol Biol. 2013;977:79–93.
   PubMedGoogle Scholar
• Zhou Q, Yang L, Larson S, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 2016;65(5):797–805.
   PubMed Web of Science ®Google Scholar
• Im K, Mareninov S, Diaz MFP, et al. An introduction to performing immunofluorescence staining. Methods Mol Biol. 2019;1897:299–311.
   PubMedGoogle Scholar
• Alexopoulou AN, Leao M, Caballero OL, et al. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res. 2010;12(4):R51.
   PubMed Web of Science ®Google Scholar
• Pijuan J, Barcelo C, Moreno DF, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.
   PubMed Web of Science ®Google Scholar
• Konstantinou GN. Enzyme-Linked Immunosorbent Assay (ELISA). Methods Mol Biol. 2017;1592:79–94.
   PubMedGoogle Scholar
• Ji F, Liu X, Wu Y, et al. Overexpression of PI3K p110 alpha contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts. Drug Des Devel Ther. 2015;9:5697–5704.
   PubMed Web of Science ®Google Scholar
• Kosem M, Tuncer I, Kotan C, et al. Significance of VEGF and microvascular density in gastric carcinoma. Hepatogastroenterology. 2009;56(93):1236–1240.
   PubMedGoogle Scholar
• Mishra P, Singh U, Pandey CM, et al. Application of student’s t-test, analysis of variance, and covariance. Ann Card Anaesth. 2019;22(4):407–411.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo J, Wang X, et al. A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells. Oncol Lett. 2018;15(5):6147–6160.
   PubMed Web of Science ®Google Scholar
• Yamaguchi N, Osaki M, Onuma K, et al. Identification of microRNAs involved in resistance to sunitinib in renal cell carcinoma cells. Anticancer Res. 2017;37(6):2985–2992.
   PubMed Web of Science ®Google Scholar
• Zhang R, Song C. Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. Tumour Biol. 2014;35(5):4419–4423.
   PubMedGoogle Scholar
• Ma C, Quesnelle KM, Sparano A, et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther. 2009;8(10):907–916.
   PubMed Web of Science ®Google Scholar
• Li S, Chen JW, Xie X, et al. Autophagy inhibitor regulates apoptosis and proliferation of synovial fibroblasts through the inhibition of PI3K/AKT pathway in collagen-induced arthritis rat model. Am J Transl Res. 2017;9(5):2065–2076.
   PubMed Web of Science ®Google Scholar
• Liu JF, Nie XC, Shao YC, et al. Bleomycin suppresses the proliferation and the mobility of human gastric cancer cells through the smad signaling pathway. Cell Physiol Biochem. 2016;40(6):1401–1409.
   PubMedGoogle Scholar
• Li M, Zhang D, Ge X, et al. TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation. Exp Cell Res. 2019;376(2):133–148.
   PubMed Web of Science ®Google Scholar
• Wang H, Shen L, Li Y, et al. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma. J Clin Pathol. 2020;73(9):579–586.
   PubMed Web of Science ®Google Scholar
• Lee SD, Yu D, Lee DY, et al. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. Cancer Sci. 2019;110(2):662–673.
   PubMed Web of Science ®Google Scholar
• Chun-Zhi Z, Lei H, An-Ling Z, et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 2010;10(1):367.
   PubMedGoogle Scholar
• Lai EC. Lai EC. microRNAs: runts of the genome assert themselves. Curr Biol. 2003;13(23):R925–936.
   PubMed Web of Science ®Google Scholar
• Kong J, Wang W. A systemic review on the regulatory roles of miR-34a in gastrointestinal cancer. Onco Targets Ther. 2020;13:2855–2872.
   PubMed Web of Science ®Google Scholar
• Kamal M, Holliday DL, Morrison EE, et al. Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. Oncol Rep. 2017;38(1):283–292.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Gong L, Wang J, et al. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). BMC Cancer. 2016;16(1):806.
   PubMedGoogle Scholar
• Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741–4751.
   PubMed Web of Science ®Google Scholar